Antithrombotic therapy after transcatheter aortic valve implantation

Leslie Marisol Lugo, Rafael Romaguera, Joan Antoni Gómez-Hospital, José Luis Ferreiro

Research output: Contribution to journalArticle

Abstract

The development of transcatheter aortic valve implantation has represented one of the greatest advances in the cardiology field in recent years and has changed clinical practice for patients with aortic stenosis. Despite the continuous improvement in operators’ experience and techniques, and the development of new generation devices, thromboembolic and bleeding complications after transcatheter aortic valve implantation remain frequent, and are a major concern due to their negative impact on prognosis in this vulnerable population. In addition, the optimal antithrombotic regimen in this scenario is not known, and current recommendations are mostly empirical and not evidence based. The present review aims to provide an overview of the current status of knowledge, including relevant on-going randomised trials, on antithrombotic treatment strategies after transcatheter aortic valve implantation.

Original languageEnglish
Article numbere09
JournalEuropean Cardiology Review
Volume15
DOIs
Publication statusPublished - 2020

Fingerprint Dive into the research topics of 'Antithrombotic therapy after transcatheter aortic valve implantation'. Together they form a unique fingerprint.

Cite this